Skip to content

Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia

Molecular Taxonomy in Pediatric Cancer- IncRNA Expression in Primary T-ALL

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01626183
Enrollment
20
Registered
2012-06-22
Start date
2012-05-31
Completion date
2016-05-31
Last updated
2016-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia

Keywords

T-cell childhood acute lymphoblastic leukemia, recurrent childhood acute lymphoblastic leukemia

Brief summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer PURPOSE: This laboratory study is looking into RNA in samples from younger patients with T-cell (T) acute lymphoblastic leukemia (ALL).

Detailed description

OBJECTIVES: * Characterization of the transcriptomic landscape in diagnosis and relapse of T-cell acute lymphoblastic leukemia (ALL) and the direct comparison with corresponding physiological samples (human thymus). * Perform high-throughput transcriptome ribonucleic acid (RNA) sequencing using matched diagnostic T-precursor pediatric ALL samples (peripheral blood or bone marrow). OUTLINE: Archived peripheral blood and bone marrow samples are analyzed for long non-coding RNA (IncRNA) expression and sequencing.

Interventions

GENETICRNA analysis
GENETICproteomic profiling
OTHERlaboratory biomarker analysis

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Children's Oncology Group
Lead SponsorNETWORK

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Peripheral blood and bone marrow samples from pediatric patients with diagnosed and relapsed T-ALL PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Design outcomes

Primary

MeasureTime frame
Identification and characterization of IncRNA of pediatric T-cell acute lymphoblastic leukemia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026